Oliver Lagore Vanvalin Investment Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $108K | Buy |
+1,490
| New | +$108K | 0.04% | 179 |
|
|
2024
Q4 | $110K | Hold |
1,490
| – | – | 0.03% | 170 |
|
|
2024
Q3 | $98.3K | Hold |
1,490
| – | – | 0.03% | 175 |
|
|
2024
Q2 | $138K | Hold |
1,490
| – | – | 0.04% | 142 |
|
|
2024
Q1 | $142K | Hold |
1,490
| – | – | 0.04% | 147 |
|
|
2023
Q4 | $114K | Sell |
1,490
-200
| -12% | -$15.3K | 0.04% | 141 |
|
|
2023
Q3 | $117K | Sell |
1,690
-10
| -0.6% | -$693 | 0.05% | 155 |
|
|
2023
Q2 | $160K | Hold |
1,700
| – | – | 0.06% | 141 |
|
|
2023
Q1 | $141K | Hold |
1,700
| – | – | 0.06% | 104 |
|
|
2022
Q4 | $127K | Sell |
1,700
-82
| -5% | -$6.12K | 0.07% | 109 |
|
|
2022
Q3 | $147K | Buy |
1,782
+18
| +1% | +$1.49K | 0.09% | 97 |
|
|
2022
Q2 | $168K | Buy |
1,764
+64
| +4% | +$6.1K | 0.1% | 98 |
|
|
2022
Q1 | $200K | Buy |
+1,700
| New | +$200K | 0.13% | 95 |
|